Deusaderm Collagen Filler Cost Review Treatment Guide.

DeusaDerm is a new injectable dermal filler that boasts several unique features due to its base of natural collagen.

What is the cost of Deusaderm?

Prices range from $1200 per syringe.

How does Deusaderm work?

Neocollagenesis: By injecting DeusaDerm into the dermis, it not only provides immediate volume and structure but also stimulates the production of new collagen. This natural collagen integration helps support existing collagen and results in a rejuvenated and more youthful appearance over time.

What are the benefits of Deusaderm?

Here are the key benefits of DeusaDerm:

  1. No Tyndall effects: Unlike some other dermal fillers, DeusaDerm does not cause the Tyndall effect. The Tyndall effect is the bluish discoloration that can occur at the site of hyaluronic acid (HA) injections, especially when treating dark eye circles. With DeusaDerm, patients can achieve an immediate eye-concealer effect without worrying about this unwanted bluish hue.
  2. Non-migratory: DeusaDerm demonstrates high viscoelasticity and cohesivity, making it less prone to migration within the skin once injected. This characteristic is particularly advantageous during nose treatments or areas where precise placement and resistance to deformation are crucial.
  3. Soft, gentle gel: DeusaDerm has a low extrusion force, which means it requires less force during injection. This easy handling is especially beneficial when treating delicate areas like the eyes, where precision correction is essential.

What is the indication for Deusa-derm?

  • acne scar treatment
  • undereye wrinkles and dark eye circles
  • facial skin rejuvenation

What is the evidence for collagen fillers in the face?

Here is a very good study conducted in Taiwan Hospital with regard to collagen fillers.

This is a prospective, randomized, active-controlled, double blinded (blinded evaluator and subject), multicenter clinical trial, which will be performed in Tri-Service General Hospital, Linkou ChangGung Memorial Hospital and National Taiwan University Hospital. These hospitals will recruit subjects in a competitive way. 240 subjects will be recruited in total, and each hospital will recruit 60~120 subjects. The expected execution period is 2018/10~2021/06. Subjects will be randomly assigned to receive the investigational device “Sumax FULLSGEN with Lidocaine” or controlled device “Sumax FACIALGAIN collagen Implant with Lidocaine” in 1:1 ratio. These devices will be processed to keep subjects and evaluators blinded.

Study Designsections

Study Type  :Interventional  (Clinical Trial)
Estimated Enrollment  :240 participants
Intervention Model:Parallel Assignment
Intervention Model Description:240 subjects will be recruited in total, and each hospital will recruit 60~120 subjects.
Masking:Double (Participant, Investigator)
Masking Description:This is a double blinded( blinded evaluator and subject) clinical trial.
Primary Purpose:Treatment
Official Title:Evaluation of Collagen Dermal Filler With Lidocaine for the Correction of Nasolabial Folds: a Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial

Leave a Reply

%d bloggers like this: